Terms: = Pancreatic cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Treatment
173 results:
1. IFN‑γ induces apoptosis in gemcitabine‑resistant pancreatic cancer cells.
Kong X; Cheng D; Xu X; Zhang Y; Li X; Pan W
Mol Med Rep; 2024 May; 29(5):. PubMed ID: 38488034
[TBL] [Abstract] [Full Text] [Related]
2. Juglone-ascorbate treatment enhances reactive oxygen species mediated mitochondrial apoptosis in pancreatic cancer.
Erkoc-Kaya D; Arikoglu H; Guclu E; Dursunoglu D; Menevse E
Mol Biol Rep; 2024 Feb; 51(1):340. PubMed ID: 38393422
[TBL] [Abstract] [Full Text] [Related]
3. A study on the role of Taxifolin in inducing apoptosis of pancreatic cancer cells: screening results using weighted gene co-expression network analysis.
Chen SJ; Ren LK; Fei XB; Liu P; Wang X; Zhu CH; Pan YZ
Aging (Albany NY); 2024 Feb; 16(3):2617-2637. PubMed ID: 38305809
[TBL] [Abstract] [Full Text] [Related]
4. CPT1B maintains redox homeostasis and inhibits ferroptosis to induce gemcitabine resistance via the KEAP1/NRF2 axis in pancreatic cancer.
Tuerhong A; Xu J; Wang W; Shi S; Meng Q; Hua J; Liu J; Zhang B; Yu X; Liang C
Surgery; 2024 May; 175(5):1264-1275. PubMed ID: 38302326
[TBL] [Abstract] [Full Text] [Related]
5. The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers.
Voissière A; Gomez-Roca C; Chabaud S; Rodriguez C; Nkodia A; Berthet J; Montane L; Bidaux AS; Treilleux I; Eberst L; Terret C; Korakis I; Garin G; Pérol D; Delord JP; Caux C; Dubois B; Ménétrier-Caux C; Bendriss-Vermare N; Cassier PA
Sci Transl Med; 2024 Jan; 16(731):eadd1834. PubMed ID: 38266104
[TBL] [Abstract] [Full Text] [Related]
6. Identification of a novel m6A-related lncRNAs signature and immunotherapeutic drug sensitivity in pancreatic adenocarcinoma.
Li XQ; Yin SQ; Chen L; Tulamaiti A; Xiao SY; Zhang XL; Shi L; Miao XC; Yang Y; Xing X
BMC Cancer; 2024 Jan; 24(1):116. PubMed ID: 38262966
[TBL] [Abstract] [Full Text] [Related]
7. Acute mast cell leukemia without kit D816V mutation and lack of CD2 and CD25-a case report of rare entity.
Zaremba-Pataj E; Patkowska E; Krzywdzińska A; Szumera-Ciećkiewicz A; Chlebowska-Tuz J
J Hematop; 2023 Mar; 16(1):39-47. PubMed ID: 38175371
[TBL] [Abstract] [Full Text] [Related]
8. [Saikosaponin D regulates apoptosis and autophagy of pancreatic cancer Panc-1 cells via Akt/mTOR pathway].
Guan YH; Liu GM; Liu YS; Lan LB; Zheng R; Liu XB
Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(19):5278-5284. PubMed ID: 38114117
[TBL] [Abstract] [Full Text] [Related]
9. The Broad Spectrum of Paediatric pancreatic Disease: A Single-center 26-years Retrospective Review.
Alnagar A; Khamag O; Sharif K; Mirza DF; Ong EGP
J Pediatr Surg; 2024 Feb; 59(2):261-267. PubMed ID: 37957099
[TBL] [Abstract] [Full Text] [Related]
10. Exploring dual effects of dinutuximab beta on cell death and proliferation of insulinoma.
Karatug Kacar A
Chem Biol Drug Des; 2024 Jan; 103(1):e14368. PubMed ID: 37802653
[TBL] [Abstract] [Full Text] [Related]
11. The therapeutic effects of exosomes the first time isolated from pancreatic islet-derived progenitor cells in the treatment of pancreatic cancer.
Hasoglu I; Karatug Kacar A
Protoplasma; 2024 Mar; 261(2):281-291. PubMed ID: 37798610
[TBL] [Abstract] [Full Text] [Related]
12. LHPP Inhibits the Viability, Migration, and Proliferation of PDAC Cells and Significantly Affects the Expression of SDC1 and S100p.
Xia Z; Zhao S; Gao X; Sun H; Yang F; Zhu H; Gao H; Lu J; Zhou X
Technol Cancer Res Treat; 2023; 22():15330338231177807. PubMed ID: 37321804
[TBL] [Abstract] [Full Text] [Related]
13. Silencing of IGHG1 reverses the resistance of pancreatic cancer to multidrug chemotherapy by modulating autophagy.
Tian Y; Han W; Fu L; Lv K; Zhou X
Environ Toxicol; 2023 Aug; 38(8):1835-1845. PubMed ID: 37186415
[TBL] [Abstract] [Full Text] [Related]
14. Petite Integration Factor 1 knockdown enhances gemcitabine sensitivity in pancreatic cancer cells via increasing DNA damage.
Wang K; Hua X; Fu X; Hao Z; Jiao A; Li S
J Appl Toxicol; 2023 Oct; 43(10):1522-1532. PubMed ID: 37183367
[TBL] [Abstract] [Full Text] [Related]
15. Agrimoniin is a dual inhibitor of AKT and ERK pathways that inhibit pancreatic cancer cell proliferation.
Zhang X; Chen J; Xi B; Liu Y; Wang S; Gu L; Zhao H; Tao L; Hua Y; Wang Y; Chen M
Phytother Res; 2023 Sep; 37(9):4076-4091. PubMed ID: 37156642
[TBL] [Abstract] [Full Text] [Related]
16. Clinical significance of serum-derived exosomal PD-L1 expression in patients with advanced pancreatic cancer.
Park SJ; Park JY; Shin K; Hong TH; Lee M; Kim Y; Kim IH
BMC Cancer; 2023 May; 23(1):389. PubMed ID: 37127565
[TBL] [Abstract] [Full Text] [Related]
17. pancreatic metastasis of extra-skeletal mesenchymal chondrosarcoma diagnosed by ultrasound endoscopy-guided fine-needle aspiration.
Xu W; Zhang Q; Chen C; Chai H; Sun C; Liu J
Rev Esp Enferm Dig; 2024 Mar; 116(3):168-169. PubMed ID: 37114405
[TBL] [Abstract] [Full Text] [Related]
18. Ubiquitin-Specific Protease 43 Impacts pancreatic Ductal Adenocarcinoma Prognosis by Altering Its Proliferation and Infiltration of Surrounding Immune Cells.
Zhao Z; Lin Z; Guo X; Al-Danakh A; He H; Qin H; Ma C; Zhang N; Tan G
J Immunol Res; 2023; 2023():4311388. PubMed ID: 37050932
[TBL] [Abstract] [Full Text] [Related]
19. Nanoparticles loaded with circ_0086375 for suppressing the tumorigenesis of pancreatic cancer by targeting the miR-646/SLC4A4 axis.
Wang Y; Zhang M; Zhang L; Zhou M; Wang E
Clin Exp Metastasis; 2023 Feb; 40(1):53-67. PubMed ID: 36479657
[TBL] [Abstract] [Full Text] [Related]
20. X-linked inhibitor of apoptosis protein is a prognostic marker for a favorable outcome in three identified subsets in resectable adenocarcinoma of the pancreas.
Knipper K; Lyu SI; Goebel H; Damanakis AI; Zhao Y; Bruns CJ; Schmidt T; Kashkar H; Quaas A; Schiffmann LM; Popp FC;
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5531-5538. PubMed ID: 36472768
[TBL] [Abstract] [Full Text] [Related]
[Next]
